Editorial: Influences in the progression of renal cell carcinoma.
作者信息
Bacchiani Mara, Grosso Antonio Andrea, Di Maida Fabrizio, Masieri Lorenzo, Minervini Andrea, Mari Andrea
机构信息
Department of Urology, University of Florence, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
出版信息
Front Oncol. 2022 Oct 14;12:1059615. doi: 10.3389/fonc.2022.1059615. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Influences in the progression of renal cell carcinoma.社论：肾细胞癌进展的影响因素
Front Oncol. 2022 Oct 14;12:1059615. doi: 10.3389/fonc.2022.1059615. eCollection 2022.
2
Expression of endothelin 2 and localized clear cell renal cell carcinoma.内皮素 2 的表达与局限性透明细胞肾细胞癌。
Hum Pathol. 2012 Jun;43(6):843-9. doi: 10.1016/j.humpath.2011.07.011. Epub 2011 Nov 1.
3
Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma.基于 RECIST1.1 标准评估转移性透明细胞肾细胞癌患者的放射进展性疾病的组成部分。
Radiology. 2019 Jul;292(1):103-109. doi: 10.1148/radiol.2019182922. Epub 2019 May 14.
4
Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.人肾癌细胞中雄激素受体mRNA表达增加与局限性肾细胞癌患者的不良预后相关。
J Urol. 2015 Nov;194(5):1441-8. doi: 10.1016/j.juro.2015.03.078. Epub 2015 Mar 18.
5
The association between statin medication and progression after surgery for localized renal cell carcinoma.他汀类药物与局限性肾细胞癌手术后进展的关系。
J Urol. 2014 Apr;191(4):914-9. doi: 10.1016/j.juro.2013.10.141. Epub 2013 Nov 26.
6
Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.基于组织芯片对肾细胞癌治疗的病理生物学、预后及治疗反应的预测
Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6304S-9S. doi: 10.1158/1078-0432.CCR-sup-040027.
7
Safety of Prolonged Wait Time for Nephrectomy for Clinically Localized Renal Cell Carcinoma.临床局限性肾细胞癌肾切除术延长等待时间的安全性
Front Oncol. 2021 Mar 30;11:617383. doi: 10.3389/fonc.2021.617383. eCollection 2021.
8
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.亚厘米级肺结节与肾细胞癌患者的疾病进展无关。
J Urol. 2015 Mar;193(3):776-82. doi: 10.1016/j.juro.2014.09.020. Epub 2014 Sep 18.
9
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.肿瘤大小不能预测小肾癌的转移风险或预后。
J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17.
10
Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.对于临床无转移的肾细胞癌，显微镜下血管侵犯是根治性肾切除术后最重要的预后指标。
J Urol. 1997 Jul;158(1):45-9. doi: 10.1097/00005392-199707000-00013.
引用本文的文献
1
Robot-assisted partial nephrectomy for renal cell carcinoma: A narrative review of different clinical scenarios.机器人辅助肾部分切除术治疗肾细胞癌：不同临床场景的叙述性综述
Asian J Urol. 2025 Apr;12(2):210-216. doi: 10.1016/j.ajur.2024.09.010. Epub 2025 Jan 25.
2
Three-dimensional virtual model for robot-assisted partial nephrectomy: a propensity-score matching analysis with a contemporary control group.机器人辅助部分肾切除术的三维虚拟模型：与当代对照组的倾向评分匹配分析。
World J Urol. 2024 May 20;42(1):338. doi: 10.1007/s00345-024-05043-9.
本文引用的文献
1
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南：2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
2
Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series.机器人辅助部分肾切除术术后肿瘤学和功能结果的头对头影响：边缘、缺血、并发症、评分与新三联评分的比较：一项多中心系列研究结果。
Eur Urol Focus. 2021 Nov;7(6):1391-1399. doi: 10.1016/j.euf.2020.06.021. Epub 2020 Jul 13.
3
Epidemiology of Renal Cell Carcinoma.肾细胞癌的流行病学
World J Oncol. 2020 Jun;11(3):79-87. doi: 10.14740/wjon1279. Epub 2020 May 14.
4
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).预测部分肾切除术的阳性手术切缘：一项前瞻性多中心观察研究（RECORd 2 项目）。
Eur J Surg Oncol. 2020 Jul;46(7):1353-1359. doi: 10.1016/j.ejso.2020.01.022. Epub 2020 Jan 22.
5
Surgical quality, cancer control and functional preservation: introducing a novel trifecta for robot-assisted partial nephrectomy.手术质量、癌症控制与功能保留：引入机器人辅助部分肾切除术的新型三连胜指标。
Minerva Urol Nefrol. 2020 Feb;72(1):82-90. doi: 10.23736/S0393-2249.19.03570-7. Epub 2019 Dec 12.
6
Renal cancer: new models and approach for personalizing therapy.肾癌：个性化治疗的新模型和方法。
J Exp Clin Cancer Res. 2018 Sep 5;37(1):217. doi: 10.1186/s13046-018-0874-4.
7
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).机器人辅助部分肾切除术治疗 T2 期临床肾肿瘤的结果：多中心分析（ROSULA 协作组）。
Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19.
8
Prognostic factors and prognostic models for renal cell carcinoma: a literature review.肾细胞癌的预后因素和预后模型：文献综述。
World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30.
9
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.肾细胞癌的预后因素和预测模型：当代综述。
Eur Urol. 2011 Oct;60(4):644-61. doi: 10.1016/j.eururo.2011.06.041. Epub 2011 Jun 30.
Zotero 插件